Cargando…
ENOblock inhibits the pathology of diet-induced obesity
Obesity is a medical condition that impacts on all levels of society and causes numerous comorbidities, such as diabetes, cardiovascular disease, and cancer. We assessed the suitability of targeting enolase, a glycolysis pathway enzyme with multiple, secondary functions in cells, to treat obesity. T...
Autores principales: | Cho, Haaglim, Lee, Ji-Hyung, Um, JungIn, Kim, Sunwook, Kim, Yukyung, Kim, Woong-Hee, Kim, Yong Sook, Pagire, Haushabhau S., Ahn, Jin Hee, Ahn, Youngkeun, Chang, Young-Tae, Jung, Da-Woon, Williams, Darren R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346001/ https://www.ncbi.nlm.nih.gov/pubmed/30679508 http://dx.doi.org/10.1038/s41598-018-36715-3 |
Ejemplares similares
-
ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes
por: Cho, Haaglim, et al.
Publicado: (2017) -
Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment
por: Kim, Yong Sook, et al.
Publicado: (2016) -
Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives
por: Lee, Eun-Hye, et al.
Publicado: (2019) -
Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819
por: Kim, Woong-Hee, et al.
Publicado: (2019) -
Screening ginseng saponins in progenitor cells identifies 20(R)-ginsenoside Rh(2) as an enhancer of skeletal and cardiac muscle regeneration
por: Kim, Ah Ra, et al.
Publicado: (2020)